» Articles » PMID: 36407760

The Emerging Power and Promise of Non-coding RNAs in Chronic Pain

Overview
Specialty Molecular Biology
Date 2022 Nov 21
PMID 36407760
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic pain (CP) is an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage lasting longer than 3 months. CP is the main reason why people seek medical care and exerts an enormous economic burden. Genome-wide expression analysis has revealed that diverse essential genetic elements are altered in CP patients. Although many possible mechanisms of CP have been revealed, we are still unable to meet all the analgesic needs of patients. In recent years, non-coding RNAs (ncRNAs) have been shown to play essential roles in peripheral neuropathy and axon regeneration, which is associated with CP occurrence and development. Multiple key ncRNAs have been identified in animal models of CP, such as microRNA-30c-5p, ciRS-7, and lncRNA MRAK009713. This review highlights different kinds of ncRNAs in the regulation of CP, which provides a more comprehensive understanding of the pathogenesis of the disease. It mainly focuses on the contributions of miRNAs, circRNAs, and lncRNAs to CP, specifically peripheral neuropathic pain (NP), diabetic NP, central NP associated with spinal cord injury, complex regional pain syndrome, inflammatory pain, and cancer-induced pain. In addition, we summarize some potential ncRNAs as novel biomarkers for CP and its complications. With an in-depth understanding of the mechanism of CP, ncRNAs may provide novel insight into CP and could become new therapeutic targets in the future.

Citing Articles

Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-kB signaling pathways.

Kaszycki J, Kim M Front Immunol. 2025; 16:1529756.

PMID: 40046056 PMC: 11879833. DOI: 10.3389/fimmu.2025.1529756.


Current and Evolving Concepts in the Management of Complex Regional Pain Syndrome: A Narrative Review.

Candan B, Gungor S Diagnostics (Basel). 2025; 15(3).

PMID: 39941283 PMC: 11817358. DOI: 10.3390/diagnostics15030353.


Epigenetic modifications associated to diabetic peripheral neuropathic pain (Review).

Gao T, Luo J, Fan J, Gong G, Yang H Mol Med Rep. 2024; 31(1).

PMID: 39540354 PMC: 11579833. DOI: 10.3892/mmr.2024.13394.


Sex as a biological variable in ageing: insights and perspectives on the molecular and cellular hallmarks.

Fritz Garcia J, Keller Valsecchi C, Basilicata M Open Biol. 2024; 14(10):240177.

PMID: 39471841 PMC: 11521605. DOI: 10.1098/rsob.240177.


Changes in Cx43 and AQP4 Proteins, and the Capture of 3 kDa Dextran in Subpial Astrocytes of the Rat Medial Prefrontal Cortex after Both Sham Surgery and Sciatic Nerve Injury.

Bretova K, Svobodova V, Dubovy P Int J Mol Sci. 2024; 25(20).

PMID: 39456773 PMC: 11507206. DOI: 10.3390/ijms252010989.


References
1.
Zhu J, Yang J, Xu J . miR-223 Inhibits the Polarization and Recruitment of Macrophages via NLRP3/IL-1 Pathway to Meliorate Neuropathic Pain. Pain Res Manag. 2021; 2021:6674028. PMC: 8367593. DOI: 10.1155/2021/6674028. View

2.
Mailhot B, Christin M, Tessandier N, Sotoudeh C, Bretheau F, Turmel R . Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases. J Exp Med. 2020; 217(9). PMC: 7478735. DOI: 10.1084/jem.20191430. View

3.
Wei M, Li L, Zhang Y, Zhang M, Su Z . Downregulated circular RNA zRANB1 mediates Wnt5a/β-Catenin signaling to promote neuropathic pain via miR-24-3p/LPAR3 axis in CCI rat models. Gene. 2020; 761:145038. DOI: 10.1016/j.gene.2020.145038. View

4.
Du S, Wu S, Feng X, Wang B, Xia S, Liang L . A nerve injury-specific long noncoding RNA promotes neuropathic pain by increasing Ccl2 expression. J Clin Invest. 2022; 132(13). PMC: 9246381. DOI: 10.1172/JCI153563. View

5.
Bali K, Selvaraj D, Satagopam V, Lu J, Schneider R, Kuner R . Genome-wide identification and functional analyses of microRNA signatures associated with cancer pain. EMBO Mol Med. 2013; 5(11):1740-58. PMC: 3840489. DOI: 10.1002/emmm.201302797. View